Clinical Trial Update: Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT [Phase 3]

View source ↗

Summary

Phase 3 trial status update compares tenecteplase with medical management for acute ischemic stroke due to large vessel occlusion in patients without access to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Vessel Occlusion
• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: The First Affiliated Hospital of University of Science and Technology of China | Conditions: Acute Ischemic Stroke, Large Vessel Occlusion | Phase 3 | Status: NOT_YET_RECRUITING